GLP-1 receptor agonists have transformed weight management for thousands of people, with clinical trials showing average weight loss between 15 and 22 percent of body weight depending on the medication and duration of treatment
J Neuroinflamm 8:78 Ray KJ et al (2014) Early addition of topical corticosteroids in the treatment of bacterial keratitis
Oral Supplement Forms Some wellness protocols include oral forms, though injections are often preferred for targeted support
pmid:16522833 5
Sergey Terushkin, MD, FACS, is a board-certified bariatric surgeon with 15+ years of experience, offering medical weight loss, GLP-1 therapies, and bariatric procedures at Florida Surgery And Weight Loss Center
If dose reduction is considered due to side effects, the FDA-approved alternative maintenance dose of 1.7 mg weekly may be appropriate